Atomo Diagnostics Ltd Ordinary Shares AT1
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.03
- Day Range
- A$0.03–0.03
- 52-Week Range
- A$0.02–0.10
- Bid/Ask
- A$0.03 / A$0.03
- Market Cap
- A$19.82 Mil
- Volume/Avg
- 291,389 / 1.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.98
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company develops the point of care devices for rapid diagnostic testing. Its device is used to test infectious diseases including COVID-19, viral vs bacterial differentiation and female health. Its offers AtomoRapid RDP Platform with devices including Galileo, Pascal, Newton, Losev, Franklin and Elion. The firm operates in a single segment, medical device research and development.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.atomodiagnostics.com
Valuation
|
Metric
|
AT1
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.45 |
Price/Sales | 5.98 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AT1
|
|---|---|
Quick Ratio | 7.06 |
Current Ratio | 8.69 |
Interest Coverage | — |
Quick Ratio
AT1
Profitability
|
Metric
|
AT1
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
AT1
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Zxlsxrp | Wkyxjq | $184.2 Bil | |
SYK
| Stryker Corp | Wwcldybd | Vvzx | $125.1 Bil | |
MDT
| Medtronic PLC | Pdtnhccb | Mcqthgx | $108.5 Bil | |
BSX
| Boston Scientific Corp | Mplwhlhh | Gcjctqg | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Ydbwqzsdl | Kjprxs | $51.4 Bil | |
DXCM
| DexCom Inc | Bmtjylgzz | Gnzc | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Stctpcbdxs | Lnm | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Jpqldtp | Dwvhsb | $24.4 Bil | |
ALGN
| Align Technology Inc | Fxlqzkps | Prlchvk | $21.7 Bil | |
PODD
| Insulet Corp | Wyydsxcd | Vdcrsf | $12.2 Bil |